Logo

pancreatic cancer

Bluestar Genomics Raises $70M in Series C Funding Round

The San Diego-based early cancer detection firm has also appointed Felix Fang and Craig Venter to its scientific advisory board. 

BostonGene, Medical College of Wisconsin Partner on Pancreatic Cancer Biomarker Research

The partners will look for patterns in patients' exome sequencing and transcriptomics data to try to predict treatment response.

Immunovia Preparing to Launch Laboratory-Developed Test for Pancreatic Cancer
Premium

The firm said that recent validation studies have shown that a positive result with its PanCan-d microarray test could accelerate diagnosis for high-risk individuals.

Guardant AACR Data Highlights Value of Clinical Test Database to Drive Drug Resistance Discoveries

Researchers used the company's large clinical-genomic database to characterize HRD reversion mutations and explore their potential function in patient resistance to PARP inhibitors.

TGen-Led Team Spots Pediatric, Pancreatic Cancer From cfDNA Fragments in Urine
Premium

The liquid biopsy method analyzes fragment ends within recurrently protected regions in cell-free DNA from a patient's urine sample.  

Feb 1, 2021

Interpace, Rutgers, Mass General Sign Deal for Pancreatic Cyst Risk Assessment Biomarker

Dec 17, 2020

Merus, Sema4 Partner to Accelerate Enrollment in Zenocutuzumab Trial

Nov 2, 2020

Bluestar Genomics Eyes Pan-Cancer Early Detection With Epigenetic Assay Technology
Premium

Oct 16, 2020

Pancreatic Cancer Subtype With Poor Outcomes Shows Low Methylation, High Interferon Signature

Oct 13, 2020

Pancreatic Cancer Action Network Launches Adaptive Clinical Trial Platform

Oct 12, 2020

Wales to Routinely Screen Cancer Patients With Yourgene Elucigene Test

Sep 24, 2020

Exact Sciences Stock Soars on New Data Around Pan-Cancer Liquid Biopsy Test

Sep 16, 2020

Startup Stitch Bio Bets on CRISPR Tech to Render Cancer Cells With Gene Fusions Druggable
Premium

Sep 15, 2020

Pancreatic Cancer Treatment Clues Uncovered From Genomic, Chromatin Profiles

Sep 9, 2020

NYGC Initiative Receives up to $2.1M for Cancer Studies in Ethnic Minorities

Jul 31, 2020

Exact Sciences Positions Itself as Cancer Testing Provider of Future as COVID Crisis Continues
Premium

Jul 29, 2020

Pancreatic Cancer Action Network, GeneCentric Therapeutics Launch Research Partnership

Jun 11, 2020

Seven Bridges Building Research Platform for PanCAN

May 29, 2020

Tumor Microbiome Appears to Vary With Cancer Type

Apr 22, 2020

Pancreatic Cancer Clinical Risk Prediction Appears to Improve With Genetic, Biomarker Data

Apr 16, 2020

Multi-Analyte Liquid Biopsy Panel May Aid in Pancreatic Cancer Detection, Staging
Premium

Apr 16, 2020

Human Tumor Atlas Network Team Shares Strategy for Tracking Tumor Transitions

Mar 30, 2020

Myriad Genetics Seeks Japan Approval for Advanced Pancreatic, Prostate Cancer Companion Diagnostic

Mar 12, 2020

Perthera's Virtual Molecular Tumor Board Can Improve Patient Outcomes, Overcome Access Barriers
Premium

Feb 11, 2020

Biological Dynamics Aims to Boost Adoption of Raw Sample Biomarker Tech Through Microsoft Program
Premium

Breaking News
The Scan

Another Resignation

According to the Wall Street Journal, a third advisory panel member has resigned following the US Food and Drug Administration's approval of an Alzheimer's disease drug.

Novavax Finds Its Vaccine Effective

Reuters reports Novavax's SARS-CoV-2 vaccine is more than 90 percent effective in preventing COVID-19.

Can't Be Used

The US Food and Drug Administration says millions of vaccine doses made at an embattled manufacturing facility cannot be used, the New York Times reports.

PLOS Papers on Frozen Shoulder GWAS, Epstein-Barr Effects on Immune Cell Epigenetics, More

In PLOS this week: genome-wide association study of frozen shoulder, epigenetic patterns of Epstein-Barr-infected B lymphocyte cells, and more.